These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31838166)

  • 1. Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival.
    McGonagle D; Bragazzi NL; Amital H; Watad A
    Autoimmun Rev; 2020 Feb; 19(2):102456. PubMed ID: 31838166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
    Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
    J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
    Berner F; Flatz L
    Immunol Rev; 2023 Sep; 318(1):37-50. PubMed ID: 37548043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
    Khan S; Gerber DE
    Semin Cancer Biol; 2020 Aug; 64():93-101. PubMed ID: 31330185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapy.
    King GT; Sharma P; Davis SL; Jimeno A
    Drugs Today (Barc); 2018 Feb; 54(2):103-122. PubMed ID: 29637937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy.
    Ohnuma K; Hatano R; Dang NH; Morimoto C
    Mod Rheumatol; 2019 Sep; 29(5):721-732. PubMed ID: 30285531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitor combinations: Current efforts and important aspects for success.
    Kon E; Benhar I
    Drug Resist Updat; 2019 Jul; 45():13-29. PubMed ID: 31382144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity.
    Singh N; Hocking AM; Buckner JH
    Immunol Rev; 2023 Sep; 318(1):81-88. PubMed ID: 37493210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.
    Schulz TU; Zierold S; Sachse MM; Pesch G; Tomsitz D; Schilbach K; Kähler KC; French LE; Heinzerling L
    Eur J Cancer; 2022 Nov; 176():88-99. PubMed ID: 36198246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy to treat malignancy in patients with pre-existing autoimmunity.
    Boland P; Pavlick AC; Weber J; Sandigursky S
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.
    Le Burel S; Champiat S; Mateus C; Marabelle A; Michot JM; Robert C; Belkhir R; Soria JC; Laghouati S; Voisin AL; Fain O; Mékinian A; Coutte L; Szwebel TA; Dunogeant L; Lioger B; Luxembourger C; Mariette X; Lambotte O
    Eur J Cancer; 2017 Sep; 82():34-44. PubMed ID: 28646772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathology of adverse events with immune checkpoint inhibitors].
    Koelzer VH; Glatz K; Bubendorf L; Weber A; Gaspert A; Cathomas G; Lugli A; Zippelius A; Kempf W; Mertz KD
    Pathologe; 2017 May; 38(3):197-208. PubMed ID: 28421272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Therapy.
    Ho AK; Ho AM; Cooksley T; Nguyen G; Erb J; Mizubuti GB
    Anesth Analg; 2021 Feb; 132(2):374-383. PubMed ID: 33009134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoint Inhibitors: Applications for Autoimmunity.
    Tocheva AS; Mor A
    Curr Allergy Asthma Rep; 2017 Sep; 17(10):72. PubMed ID: 28956259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series.
    Kim ST; Tayar J; Trinh VA; Suarez-Almazor M; Garcia S; Hwu P; Johnson DH; Uemura M; Diab A
    Ann Rheum Dis; 2017 Dec; 76(12):2061-2064. PubMed ID: 28830882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for immune-related adverse events associated with immune checkpoint inhibitors.
    Chen YH; Kovács T; Ferdinandy P; Varga ZV
    Br J Pharmacol; 2024 May; ():. PubMed ID: 38803135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity.
    Thanarajasingam U; Abdel-Wahab N
    Rheum Dis Clin North Am; 2020 Aug; 46(3):587-603. PubMed ID: 32631606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe neurologic complications of immune checkpoint inhibitors: a single-center review.
    Mancone S; Lycan T; Ahmed T; Topaloglu U; Dothard A; Petty WJ; Strowd RE
    J Neurol; 2018 Jul; 265(7):1636-1642. PubMed ID: 29761297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity.
    Shatila M; Ma W; Cui Y; Naz S; S Thomas A; N De Toni E; Török HP; Khaled NB; Altan M; Schneider B; Wang Y
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7793-7803. PubMed ID: 37029815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience.
    Mooradian MJ; Nasrallah M; Gainor JF; Reynolds KL; Cohen JV; Lawrence DP; Miloslavsky EM; Kohler MJ; Sullivan RJ; Schoenfeld SR
    Semin Arthritis Rheum; 2019 Jun; 48(6):1127-1132. PubMed ID: 30409415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.